drugset / Trial / NCT06890429
Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults
Phase 2
Completed
120 enrolled
Research Institute of Influenza, Russia
Pavlov First Saint Petersburg State Medical University · collabSt. Petersburg City Polyclinic No. 34 · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The aim of the study is to investigate immunogenicity and safety of the RSV/Flu-01E intranasal vaccine for the prevention of respiratory syncytial virus infection in volunteers over 60 years
Timeline
- Start
- 2023-12-07
- Primary completion
- 2024-01-08
- Completion
- 2024-04-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RSV/Flu-01E | Vaccine | 0.5 ml | Intranasal |